Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06767514
PHASE3

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Sponsor: Summit Therapeutics

View on ClinicalTrials.gov

Summary

Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival.

Official title: A Randomized, Double-blinded, Multiregional Phase 3 Study of Ivonescimab Versus Pembrolizumab for the First-line Treatment of Metastatic Non-small Cell Lung Cancer in Patients Whose Tumors Demonstrate High PD-L1 Expression

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

780

Start Date

2025-02-27

Completion Date

2029-06

Last Updated

2026-09-18

Healthy Volunteers

No

Interventions

BIOLOGICAL

Ivonescimab Injection

Subject will receive ivonescimab as an IV injection

BIOLOGICAL

Pembrolizumab Injection

Subject will receive Pembrolizumab as an IV injection

Locations (285)

Clinical Study Site

Chandler, Arizona, United States

Clinical Study Site

Phoenix, Arizona, United States

Clinical Study Site

Hot Springs, Arkansas, United States

Clinical Study Sites

Jonesboro, Arkansas, United States

Clinical Study Site

Alameda, California, United States

Clinical Study Site

Anaheim, California, United States

Clinical Study Site

Beverly Hills, California, United States

Clinical Study Site

Cerritos, California, United States

Clinical Study Site

Los Angeles, California, United States

Clinical Study Site

Los Angeles, California, United States

Clinical Study Site

Orange, California, United States

Clinical Study Site

Oxnard, California, United States

Clinical Study Site

San Diego, California, United States

Clinical Study Site

Sunnyvale, California, United States

Clinical Study Site

Torrance, California, United States

Clinical Study Site

Aurora, Colorado, United States

Clinical Study Site

Denver, Colorado, United States

Clinical Study Site

Grand Junction, Colorado, United States

Clinical Study Site

Lone Tree, Colorado, United States

Clinical Study Site

Loveland, Colorado, United States

Clinical Study Sites

Fort Lauderdale, Florida, United States

Clinical Study Site

Fort Lauderdale, Florida, United States

Clinical Study Site

Jacksonville, Florida, United States

Clinical Study Site

Jacksonville Beach, Florida, United States

Clinical Study Site

North Venice, Florida, United States

Clinical Study Site

Ocala, Florida, United States

Clinical Study Site

Orlando, Florida, United States

Clinical Study Site

Pensacola, Florida, United States

Clinical Study Site

Plantation, Florida, United States

Clinical Study Site

St. Petersburg, Florida, United States

Clinical Study Site

Tallahassee, Florida, United States

Clinical Study Site

Tamarac, Florida, United States

Clinical Study Site

West Palm Beach, Florida, United States

Clinical Study Site

Atlanta, Georgia, United States

Clinical Study Site

Warner Robins, Georgia, United States

Clinical Study Site

Carterville, Illinois, United States

Clinical Study Site

Chicago, Illinois, United States

Clinical Study Site

Chicago, Illinois, United States

Clinical Study Site

Evanston, Illinois, United States

Clinical Study Site

Indianapolis, Indiana, United States

Clinical Study Site

Waukee, Iowa, United States

Clinical Study Site

Lexington, Kentucky, United States

Clinical Study Site

Covington, Louisiana, United States

Clinical Study Site

Baltimore, Maryland, United States

Clinical Study Site

Boston, Massachusetts, United States

Clinical Study Site

Brighton, Massachusetts, United States

Clinical Study Site

Foxborough, Massachusetts, United States

Clinical Study Site

Methuen, Massachusetts, United States

Clinical Study Site

Milford, Massachusetts, United States

Clinical Study Site

Weymouth, Massachusetts, United States

Clinical Study Site

Worcester, Massachusetts, United States

Clinical Study Site

Ann Arbor, Michigan, United States

Clinical Study Site

Detroit, Michigan, United States

Clinical Study Sites

Detroit, Michigan, United States

Clinical Study Sites

Duluth, Minnesota, United States

Clinical Study Site

Minneapolis, Minnesota, United States

Clinical Study Site

Saint Paul, Minnesota, United States

Clinical Study Site

Hattiesburg, Mississippi, United States

Clinical Study Site

Kansas City, Missouri, United States

Clinical Study Site

St Louis, Missouri, United States

Clinical Study Site

St Louis, Missouri, United States

Clinical Study Site

Lebanon, New Hampshire, United States

Clinical Study Site

Mullica Hill, New Jersey, United States

Clinical Study Site

New Brunswick, New Jersey, United States

Clinical Study Site

New York, New York, United States

Clinical Study Site

Syracuse, New York, United States

Clinical Site

The Bronx, New York, United States

Clinical Study Site

Chapel Hill, North Carolina, United States

Clinical Study Site

Durham, North Carolina, United States

Clinical Study Site

Pinehurst, North Carolina, United States

Clinical Study Sites

Cincinnati, Ohio, United States

Clinical Study Site

Cleveland, Ohio, United States

Clinical Study Sites

Columbus, Ohio, United States

Clinical Study Site

Columbus, Ohio, United States

Clinical Study Site

Oklahoma City, Oklahoma, United States

Clinical Study Site

Eugene, Oregon, United States

Clinical Study Site

Portland, Oregon, United States

Clinical Study Site

Philadelphia, Pennsylvania, United States

Clinical Study Site

Pittsburgh, Pennsylvania, United States

Clinical Study Site

Greenville, South Carolina, United States

Clinical Study Sites

Nashville, Tennessee, United States

Clinical Study Site

Nashville, Tennessee, United States

Clinical Study Site

Abilene, Texas, United States

Clinical Study Site

Austin, Texas, United States

Clinical Study Site

Dallas, Texas, United States

Clinical Study Site

Fort Worth, Texas, United States

Clinical Study Site

Houston, Texas, United States

Clinical Study Site

Tyler, Texas, United States

Clinical Study Site

Webster, Texas, United States

Clinical Study Site

Salt Lake City, Utah, United States

Clinical Study Site

Blacksburg, Virginia, United States

Clinical Study Site

Charlottesville, Virginia, United States

Clinical Study Site

Fairfax, Virginia, United States

Clinical Study Site

Richmond, Virginia, United States

Clinical Study Site

Richmond, Virginia, United States

Clinical Study Site

Seattle, Washington, United States

Clinical Study Site

Vancouver, Washington, United States

Clinical Study Site

Mons, Hainaut, Belgium

Clinical Study Site

Charleroi, Belgium

Clinical Study Site

Ghent, Belgium

And 185 more locations on ClinicalTrials.gov